Green tea polyphenols block the anticancer effects of bortezomib and other boronic acid–based proteasome inhibitors
Open Access
- 4 June 2009
- journal article
- Published by American Society of Hematology in Blood
- Vol. 113 (23) , 5927-5937
Abstract
The anticancer potency of green tea and its individual components is being intensely investigated, and some cancer patients already self-medicate with this “miracle herb” in hopes of augmenting the anticancer outcome of their chemotherapy. Bortezomib (BZM) is a proteasome inhibitor in clinical use for multiple myeloma. Here, we investigated whether the combination of these compounds would yield increased antitumor efficacy in multiple myeloma and glioblastoma cell lines in vitro and in vivo. Unexpectedly, we discovered that various green tea constituents, in particular (-)-epigallocatechin gallate (EGCG) and other polyphenols with 1,2-benzenediol moieties, effectively prevented tumor cell death induced by BZM in vitro and in vivo. This pronounced antagonistic function of EGCG was evident only with boronic acid–based proteasome inhibitors (BZM, MG-262, PS-IX), but not with several non–boronic acid proteasome inhibitors (MG-132, PS-I, nelfinavir). EGCG directly reacted with BZM and blocked its proteasome inhibitory function; as a consequence, BZM could not trigger endoplasmic reticulum stress or caspase-7 activation, and did not induce tumor cell death. Taken together, our results indicate that green tea polyphenols may have the potential to negate the therapeutic efficacy of BZM and suggest that consumption of green tea products may be contraindicated during cancer therapy with BZM.Keywords
This publication has 47 references indexed in Scilit:
- Synergistic inhibition of head and neck tumor growth by green tea (−)‐epigallocatechin‐3‐gallate and EGFR tyrosine kinase inhibitorInternational Journal of Cancer, 2008
- Tea and cancer prevention: Molecular mechanisms and human relevanceToxicology and Applied Pharmacology, 2007
- The Unfolded Protein Response Regulator GRP78/BiP as a Novel Target for Increasing Chemosensitivity in Malignant GliomasCancer Research, 2007
- Green Tea Consumption and Prostate Cancer Risk in Japanese Men: A Prospective StudyAmerican Journal of Epidemiology, 2007
- Tea polyphenols for health promotionLife Sciences, 2007
- Inhibition of mammary tumorigenesis in the C3(1)/SV40 mouse model by green teaBreast Cancer Research and Treatment, 2007
- Cancer Preventive Mechanismsof the Green Tea Polyphenol (-)-Epigallocatechin-3-gallateMolecules, 2007
- Specific killing of multiple myeloma cells by (-)-epigallocatechin-3-gallate extracted from green tea: biologic activity and therapeutic implicationsBlood, 2006
- Multitarget inhibition of drug-resistant multiple myeloma cell lines by dimethyl-celecoxib (DMC), a non–COX-2 inhibitory analog of celecoxibBlood, 2005
- Bortezomib or High-Dose Dexamethasone for Relapsed Multiple MyelomaNew England Journal of Medicine, 2005